Clinical Trial Update: Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of COMBIGAN in Korean patients with primary open-angle glaucoma and normal tension glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Normal Tension Glaucoma

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Normal Tension Glaucoma | Phase 4 | Status: COMPLETED